RxDoctor Payments Data

Michelle Jones

Family · Burlingame, CANPI 1609598028

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $135,219 of the $147,180 with a category attached, or 91.9%. Galderma Laboratories, L.p. accounts for 85.5% of it on its own, with 3 other manufacturers making up the rest. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$147,180in general payments, 2019–2025

Across 259 payments — averaging $568.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$126K
  • AbbVie$21K
  • Revance Therapeutics, Inc.$197
  • Merz North America, Inc.$159

What the payments were for

  • Consulting fees$6700%
  • Speaking & faculty fees$135,21992%
  • Travel & lodging$7,0775%
  • Food & beverage$4,1983%
  • Education$170%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.142$125,839
AbbVie(2 entities)104$20,984
Revance Therapeutics, Inc.7$197
Merz North America, Inc.6$159

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$147,180 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California →

Other family in Burlingame

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →